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Electrospinning: processing technique for
tissue engineering scaffolding
A. Martins*1,2, R. L. Reis1,2 and N. M. Neves1,2
Electrospinning has attracted tremendous interest in the research community as a simple and
versatile technique to produce synthetic polymeric ultrafine fibres with diameters ranging from a
few micrometres to tens of nanometres. Recently, some natural origin polymers have also been
successfully electrospun. Owing to their very small diameter, polymeric nanofibres exhibit
unusual properties such as high specific surface area, flexibility in surface functionalities and
superior mechanical properties. In addition, electrospun non-woven meshes could physically
mimic the extracellular matrix structure of native tissues. These remarkable properties render
electrospun nanofibres useful for many applications, particularly those related to the field of
biomedical engineering. The first part of this review is intended to provide a fundamental survey
of the electrospinning process (apparatus, governing parameters) and of recent improvements of
the technique, including associated structural modifications of polymeric nanofibre meshes. The
prospective tissue engineering/biomedical applications of electrospun polymeric nanofibres are
then reviewed, namely, wound dressings, medical prostheses, drug delivery systems, DNA
release and tissue engineering scaffolds. The essential properties of scaffolds in terms of the
structural features of electrospun nanofibre meshes are discussed. Finally, the future
perspectives for applications of electrospun nanofibres, particularly in the field of tissue
engineering, are considered.
Keywords: Electrospinning process, Tissue engineering, Biodegradable scaffolds, Nanofibrous structures, Wound dressing, Medical prostheses, Drug
delivery systems, DNA release systems
Introduction
Nanostructures and the nanotechnologies to produce
them have been a subject of intensive research due to the
unique properties that can be obtained and their
potential applications in many areas. A large number
of technologies have already been demonstrated as being
able to generate nanostructures in the form of
fibres,54,155 among them electrospinning. The electro-
spinning technique may be considered as a variation of
the electrostatic spraying (or electrospraying) process,31
used in technologies such as time of flight secondary ion
mass spectrometry175 and other spectrometric meth-
ods.18 In electrospraying, small droplets or particles are
formed as a result of the varicose break-up of the
electrified jet that is often present with a solution of low
viscosity.41 In electrospinning, a solid fibre (composed of
a viscous polymer solution) is produced by the generated
electrical field. Subsequently, nanofibres are formed by
continuous stretching, due to the electrostatic repulsion
between the charged nanofibres and the evaporation of
the solvent.31
Although the term ‘electrospinning’, derived from
‘electrostatic spinning’, was proposed relatively recently
(around 1994), its origin as a viable fibre spinning
technique can be traced back to the mid 1930s.
Formhals37 patented, in 1934, his first invention,
describing the process and the apparatus for producing
artificial filaments using electrical charges. In 1964,
Taylor167 developed fundamental studies on the jet
formation process. The observed conical shape of the jet
was later referred by other researchers as the ‘Taylor
cone’. In subsequent years, the focus shifted to studying
the structural morphology of nanofibres owing to the
development of atomic force microscopy (AFM),
transmission electron microscopy (TEM) and even
scanning electron microscopy (SEM) tools.
Researchers were occupied with the structural charac-
terisation of fibres and the understanding of the
relationship between the structural features and process
parameters.13,26,27,31,38,113,134,166,192 A major upsurge in
electrospinning research took place due to the applica-
tion potential of nanofibres in areas such as filtration
systems, protective clothing, catalyst substrates, photo-
nics, sensors and tissue engineering scaffold-
ing.29,54,87,102,163 Strangely enough, although the
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electrospinning process has been known for more than
70 years, the mechanism by which nanofibres is formed
is not fully understood. Although a number of studies
have been carried out to investigate the mechanism of
fibre formation in order reproducibly to control scaffold
design, little theoretical understanding has been
achieved.
According to the review by Huang et al.,54 more than
100 different polymers have been successfully spun into
ultrafine fibres using this technique (most dissolved
in solvents yet some electrospun from melt) for
various applications. The potential applications in cell
biology and tissue engineering has resulted in a large
number of biodegradable polymers being electro-
spun into nanofibres, including poly (caprolactone)
(PCL),7,89,91,94,125,130,193 poly(lactic acid)72,191,197
(PLA), poly(glycolic acid) (PGA)15,16 and poly(lactide-
co-glycolide) (PLGA).90,100,139,186 In addition to these
synthetic biodegradable polymers, natural biopolymers,
such as DNA,34,134 silk fibroin,62,82,115,116 fibrino-
gen,111,183 dextran,59 collagen109,110,149,202 and chito-
san42,126 have been successfully processed by
electrospinning. Relative to synthetic polymers, natural
origin polymers have good biocompatibility; conversely,
their processability is, in general, poor.
A number of functional polymers envisaged for
specific applications have been directly electrospun into
nanofibres. However, many functional polymers are not
suitable for use with electrospinning, because of their
limited molecular weights and/or solubilities. One of the
most effective strategies for solving this problem is to
blend them with polymers that are well suited for
electrospinning.87 This is a feasible approach that may
not only reduce the potential problem of cytotoxicity, as
a result of using a chemical cross-linking reagent, but
also provides a well designed solution for overcoming
the shortcomings of synthetic and natural polymers.
Indeed, the production of new biomaterials with good
biocompatibility and improved mechanical and physi-
cal/chemical properties has been achieved.52,60,117,199,201
Electrospinning is an attractive approach for polymer
biomaterials processing, providing an opportunity to
control morphology, porosity and composition using
relatively unsophisticated equipment. Unlike conven-
tional fibre spinning processes that produce fibres with
diameters in the micrometre range,174 electrospinning is
capable of producing fibres in the nanometre diameter
range, which are typically deposited in the form of non-
woven fabrics. Nanofibres provide a connection between
the nanoscale and the macroscale world, since although
their diameters are in the nanometre range, they are very
long entities, sometimes of the order of kilometres.134
Even the largest diameters produced by electrospinning
are more than 10 times smaller than those that can be
extruded to manufacture textile structures and woven
mats.
When the diameters of polymer fibre materials are
shrunk from the micrometre (e.g. 10–100 mm) to the
submicrometre or nanometre scale (e.g. 10–100 nm),
several interesting properties arise, such as very large
surface area to volume ratio (which for a nanofibre can
be 1000 times of that of a microfibre), flexibility in
surface functionalities and superior mechanical perfor-
mance (e.g. stiffness and tensile strength) compared with
any other known form of the material.54 It is known that
the natural extracellular matrix (ECM) of various tissues
is composed of randomly oriented collagen fibres with
nanometre scale diameters. Indeed, the architecture of
the electrospun nanofibrous structure is dimensionally,
but not morphologically, similar to those of some
natural ECMs.102,155 The non-woven mats produced
have the additional advantages of controllable pore size,
high porosity with interconnected pores and perme-
ability.68,193 These outstanding properties make the
polymer nanofibres effective candidates for many
important applications, particularly for tissue engineer-
ing/biomedical applications.
The present review is organised into three main
sections. First, the fundamentals of the electrospinning
process are considered; this survey includes an overview
of the electrospinning apparatus and the parameters
governing the process (the effects of these processing
parameters have been reviewed in detail previously).1,138
Recent developments of the electrospinning process
enabling production of different nanofibrous structures
(e.g. core/sheath combinations, hollow, porous or
aligned nanofibres) are also reviewed (some of these
nanofibre structures have been reviewed pre-
viously).48,121
The following section provides an extensive discussion
of the potential tissue engineering/biomedical applica-
tions of electrospun nanofibres, such as wound dressing,
medical prostheses, drug delivery systems, DNA release
and tissue scaffolding, with a focus on the electrospun
polymer structures and biological evidence. This
approach is intended to capture the state of the art of
understanding for each type of biomedical application
and is the distinctive feature of the present review: a
critical assessment of electrospinning as a technique to
produce tissue engineered scaffolds. While similar
information has been presented in other
reviews,5,9,92,108,123,129,170,200 these articles have not
covered these tissue engineering/biomedical applications
in comparable depth.
The next section reviews scaffold target properties and
the extent that these have been achieved by electrospin-
ning nanofibres. The achievements to date and the
deviations from the target properties are of utmost
importance in identifying the process improvements
required to obtain the tailored nanofibrous scaffolds
needed for tissue engineering applications. The review
concludes with a section covering future perspectives on
applications and opportunities raised by the develop-
ment of electrospinning, particularly in the field of tissue
engineering.
Electrospinning process
Electrospinning involves applying a very high voltage to
a capillary filled with the polymer solution to be spun.
Mutual charge repulsion induced by the electrical field
causes a force directly opposite to the surface tension of
the polymer fluid. As the intensity of the electrical field is
increased, the hemispherical surface of the fluid at the tip
of the capillary tube elongates to form a conical shape,
known as ‘Taylor cone’, observable in various spinning
techniques. With increasing electrostatic field, a critical
value is attained when the repulsive electrostatic force
overcomes the surface tension of the polymer solution
and a charged jet of fluid is ejected from the tip of the
Taylor cone.31,134
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As the jet progresses from the capillary towards the
collector, the forces from the external electrical field
accelerate and stretch the jet. Stretching and evaporation
of the solvent molecules cause the jet diameter to
become smaller. As the radius of the jet becomes
smaller, the radial forces from the charge can become
large enough to overcome the cohesive forces of the fibre
and cause it to split into two or more fibres, that is, to
splay. This jet division process occurs several more times
in rapid succession and produces a large number of
small electrically charged fibres moving toward the
collector. The divided jets repel each other, thereby
acquiring lateral velocities and chaotic trajectories,
which gives a brush like appearance in the region
beyond the point at which the jet first splays. Splaying
and elongation appear to occur simultaneously in many
cases.134 However, recent observations of Yarin et al.192
suggest that the jet, while moving towards the collector,
undergoes a chaotic motion or bending instability, due
to the repulsive forces originating from the charged ions
within the electrospinning jet. Because electrospinning is
a continuous process, the fibres could be as long as
several kilometres. In the electrospinning process, these
long fibres can be assembled into a three-dimensional,
non-woven mat as a result of bending instability of the
spinning jet (Fig. 1).
Electrospinning apparatus
There are basically three components to complete a
functional electrospinning set-up: a high voltage power
supply, a spinneret constituted by a glass capillary tube
or a needle of small diameter, and a grounded metal
collecting screen (Fig. 2). The electrospinning apparatus
is usually set up in a chemical hood to allow the
exhaustion of organic vapours. In addition, a closed,
non-conductive environment with temperature and
humidity control is required to avoid interference from
environmental factors, such as air turbulence.92 Several
groups working on electrospinning have adopted
different solutions for the polymer flow through the
needle.14,73,104 Some have simply opted for placing the
capillary perpendicularly, letting the polymer fluid drop
under gravity and placing the collector underneath.73
Sometimes the capillary can be tilted at a defined angle
to control the flowrate through the capillary.104 Other
authors mount the capillary horizontally and a pump is
used to initiate the droplet. The pump is also used in the
case of vertical feeding.14 The electrode can be inserted
either in the polymer fluid or placed onto the tip of the
capillary if a syringe with a metal needle is used.38 The
collector is usually a plane metal sheet or a grid that can
be covered with a fabric, although rotating cylinders
covered with a grounded aluminium sheet could also be
used.70
Most polymers commonly used in electrospinning are
dissolved in appropriated solvents before being electro-
spun.31,54,134,163 Molten polymers can also be processed
into nanofibres through electrospinning (usually at
relatively high temperatures);101 the polymer melt is
introduced direct into the capillary tube rather than the
solution. However, electrospinning of a polymer melt
must be performed in a vacuum condition.
Governing parameters
The foregoing discussion suggests that the following
parameters significantly affect the electrospinning
process:
(i) intrinsic solution properties: viscosity, elasticity,
conductivity and surface tension13,26,31
(ii) operational conditions: hydrostatic pressure in
the capillary tube, electrical potential at the
capillary tip, capillary diameter and distance
between tip and collecting screen38,125
(iii) ambient parameters such as solution tempera-
ture, humidity and air velocity in the
electrospinning chamber.113,163
By appropriate tuning of one or more of these
parameters, fibres may be successfully electrospun from
water soluble polymers, biopolymers or liquid crystalline
polymers.
Generally, the polymer solution must have a concen-
tration high enough to have sufficient number of
polymer entanglements yet not so high that the viscosity
prevents the polymer flow induced by the pump and the
stretching caused by the electrical field. The solution
must also have a surface tension low enough, a charge
density high enough and a viscosity high enough to
prevent the jet from coalescing into droplets before the
solvent has evaporated.31 In the electrospinning process,
the properties of the solvent, such as volatility and
polarity (dielectric constant), have a significant influence
on the morphology and diameter of the electrospun
fibres. The electrospinning of a polymer in a polar
solvent generally produces ultrathin fibres with smaller
1 SEM images of polycaprolactone (PCL) nanofibres in
mesh, produced by electrospinning
2 Schematic representation of electrospinning apparatus
(adapted from Ref. 125)
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average diameters, although the effect of solvent
polarity on the fibre diameters has not been system-
atically studied.13 Morphological changes can occur
upon decreasing the distance between the spinneret and
the collector. Increasing the distance or decreasing the
electrical field decreases the probability of beads in the
mesh, regardless of the concentration of the polymer in
solution.38
As long as a polymer can be electrospun into
nanofibres, ideal targets would be:
(i) that fibre diameters be uniform, consistent and
controllable
(ii) that the fibre surface be defect free
(iii) that continuous single nanofibres be collectable.
However, to date, these three targets have proved by no
means easily achievable. As long as no splitting is
involved, one of the most significant parameters
influencing fibre diameter is solution viscosity: high
viscosity results in a larger fibre diameter. In general,
fibre diameter tends to decrease with increasing electro-
spinning voltage, although the influence is not as strong
as that of the polymer concentration. An additional
challenge is to control the uniformity of fibre diameters
with current electrospinning equipment.26,27,31,113 The
base of the Taylor cone when formed is equal to the
orifice diameter of the needle. Therefore, it was
hypothesised that a change in the base of the Taylor
cone will potentially influence the forces necessary for its
formation, the formation of the jet and thus the
diameter of the nanofibres. As predicted, a decrease in
the base of the Taylor cone (orifice diameter) caused a
decrease in the average diameter of the nanofibres
formed.54
The structure and morphology of electrospun fibres is
also affected by the spinneret tip to collector distance
because of their dependence on the deposition time,
evaporation rate and whipping or instability regions.
Shorter spinneret tip collector distances tend to produce
wetter fibres and beaded structures. Thus, aqueous
polymer solutions require longer distances to dry fibre
formation than systems that use highly volatile organic
solvents. The flowrate of the polymer at the syringe is
another important process parameter, since it influences
jet velocity and material transfer rate. Therefore, the
fibre diameters and the pore size are larger when the
polymer flowrate is higher. Increased flowrate
also increases the tendency to form beaded morpholo-
gies.113 Indeed, a common problem encountered in
electrospinning is the formation of structure defects,
such as beads and pores caused by local excess of
solvent, which may occur in polymer nanofibres
(Fig. 3).51 The beads may form as a result of an
instability in jet initiation, which is correlated with
properties of the polymer solution (viscosity and surface
tension) as well as there being insufficient force to
stretch the polymer jet. This effect may be due to the
electrical field or to the boundary conditions such as
spinneret tip diameter. In other words, it is more likely
to be possible to electrospin bead free fibres from thicker
spinneret tips with higher polymer concentration solu-
tion. Fibre diameter could be significantly decreased by
decreasing polymer concentration, although there is a
limit to obtain uniform nanofibres without beads.
Furthermore, adding filler material into a polymer
solution can also result in fibres free from beads.54
Recent developments on electrospinning
process
Electrospinning apparatus is simple in construction and
there have been no significant developments in the
equipment design in the past decade. Some research
groups7,33,86, 125,194,199,202 have improvised the basic
electrospinning set-up to suit their experimental needs in
terms of materials and applications. In improve control
of the electrospinning process and thus, tailor the
structures of resultant fibres, the set-up (in particular,
the collector and the spinneret) has also been modified.
In general, electrospinning is a process with limited
productivity because the polymer solution has to be fed
at relatively slow rates (usually less than 1 mL h21), to
obtain ultrathin fibres. Productivity enhancement for
commercialising products obtained by electrospinning
is under active research, with emphasis on multiple
spinneret designs, and alternative experimental set-ups
have recently been demonstrated.33 However, there is
still debate on the potential of scaling up this technology
for commercialisation. From the available published
literature and the current state of understanding of the
electrospinning process, it is likely that commercial
scaling-up of the electrospinning process will be
achieved only when a more fundamental understanding
of the process and better control of the instability
behaviour of the jets is achieved.
The conventional set-up for electrospinning involves
the use of a single capillary as the spinneret and thus is
suitable only for generating fibres with one particular
composition in each run of fabrication, exhibiting a solid
interior and a smooth surface. Recent demonstrations
established that nanofibres with some specific secondary
structures (e.g. core/sheath or hollow, and porous) could
also be prepared if appropriated processing parameters
(e.g. electrical field strength, concentration of solution
and feedrate of solution) or new designs of spinnerets
were employed. With the use of the conventional
electrospinning set-up, it is possible to fabricate core/
sheath nanofibres from a polymer solution containing
two polymers that will phase separate as the solvent is
evaporated. Core/sheath or hollow nanofibres could also
be fabricated by coelectrospinning of two different
polymeric solutions through a spinneret comprising
two coaxial capillaries53,61,83,86,97,199 (Fig. 4). It has thus
amply been demonstrated that electrospinning is
capable of fabricating nanostructures with complex
3 SEM image of polyvinylpyrrolidone (PVP) nanofibres
with beads in its structure
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functionalities. It is also speculated that it will be
possible to fabricate hollow nanofibres with multiple
walls using a spinneret composed of more than two
coaxial capillaries.87
The specific surface area of a nanofibre can be greatly
increased when its structure is switched from solid to
porous.97 Increase in surface areas is beneficial to many
applications that include catalysis, filtration, absorption,
fuel cells, solar cells, batteries or tissue engineering. Two
slightly different approaches have been reported to
introduce a porous structure into the bulk of an
electrospun nanofibre. One is based on the selective
removal of one component used to produce nanofibres
made from a two phase material, such as a composite or
a blend. The other involves the use of phase separation
technology during electrospinning with appropriate
spinning parameters13 (Fig. 5).
Most nanofibres obtained to date are in the non-
woven form, which can be useful for a small number of
applications such as filtration, tissue engineering scaf-
folds, implant coating film, and wound dressing.
However, by analogy with the traditional fibre and
textile industry, only when continuous single nanofibres
or uniaxial fibre bundles are obtained will their range of
applications be expanded. This is a very tough target to
achieve with electrospun nanofibres, because the poly-
mer jet trajectory is a complex three-dimensional
‘whipping’ path, caused by bending instability, rather
than a straight line. To date, no continuous long fibre
yarn has been reported and the publications related to
aligned nanofibres are very limited.54 It has been
suggested that by rotating a cylinder collector at a very
high speed (up to thousands of revolutions per minute),
electrospun nanofibres could be oriented circumferen-
tially (e.g. PGA and type I collagen).70 However, fibre
alignment was achieved only to some extent. The reason
why a perfect alignment is difficult to achieve can be
attributed to the fact that the chaotic motions of
polymer jets are not likely to be coherent and are not
controllable. Even so, a large amount of work has been
carried out in the field of nanofibre alignment, regarding
the use of rotating systems as collectors in the
electrospinning process.7,80,91,124,165,169,187,190 A signifi-
cant advance in collecting aligned electrospun nanofi-
bres has been made by Theron et al.,171 who described a
novel approach to position and align individual
nanofibres on a tapered and grounded wheel like
bobbin. The tip like edge substantially concentrates the
electrical field so that the as spun nanofibres are almost
all attracted to and continuously wound onto the bobbin
edge of the rotating wheel.
Investigation is continuing to understand the align-
ment characteristics in terms of varying the shape and
size of frame rods, the distance between the frame rods,
and the inclination angle of a single frame.54 Fong et al.36
obtained aligned nylon 6 fibres by rapidly oscillating a
grounded frame within the electrospun polymer jets. In
another approach, it was demonstrated that using a
multiple field technique, the polymer jet, usually in
chaotic oscillating motion as it approaches the collection
target, can be straightened to some extent.27 Li et al.84
recently demonstrated that the geometrical configura-
tion of a conductive collector had a profound effect on
the orientation of electrospun nanofibres (Fig. 6). Using
a collector consisting of two conductive strips separated
by a gap of variable width (up to several centimetres),
electrospun fibres could be uniaxially aligned over long
lengths during the spinning process.28,85,146 This collect-
ing process has been termed the ‘gap method of
alignment’, and it results in single electrospun fibres,
oriented and suspended between two collection plates.
4 A schematic illustration of set-up for electrospinning nanofibres having core/sheath structure: system is based in spin-
neret with two coaxial capillaries, and B SEM image of uniaxially aligned array of TiO2 hollow fibres after both mineral
oil extraction from core and calcinations (adapted from Ref. 86: !2004 ACS)
5 SEM images of PLLA fibres with pores at surface
obtained via electrospinning of solution of PLLA in
dichloromethane (from Ref. 13: !2001 Wiley-VCH
Verlag)
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In a different strategy, copper wires spaced evenly in the
form of a circular drum as a collector resulted in sheets
with 1 cm wide strips of aligned nanofibres.64 In a recent
paper, Teo and Ramakrishna170 described a simple
method of obtaining a fibre bundle of micrometre scale
diameter from nanofibres aligned between two parallel
steel blades with a gap between them. A similar structure
composed of aligned nanofibres, developed by
Dalton and colleagues,25 was obtained using two
grounded collection rings or circular discs equidistant
from the spinneret, by rotating one of the collection
rings.
It may also be possible to integrate electrospinning
with conventional lithographic techniques to obtain new
fabrication platforms for generating patterned micro-
structures from a variety of materials and a broad range
of length scales. Czaplewski et al.24 deposited nanofibres
of poly(methyl methacrylate) as templates for the
formation of functional nanomechanical devices (e.g.
nanomechanical oscillators), combined with lithogra-
phically defined support structures. Afterwards, Liu and
collaborators96 developed sensor devices that utilized
individual oriented polymeric nanowires of polyaniline/
poly(ethylene oxide) deposited on lithographically
defined microelectrodes.
Tissue engineering/biomedical
applications of electrospun nanofibres
From a biological perspective, almost all human tissues
and organs are deposited in some kind of nanofibrous
form or structure.155 Examples include, among many
others, bone, collagen, cartilage and skin.2,148,195 All of
these are characterised by well organised hierarchical
fibrous structures realigning on a nanometre scale.160 As
such, current research in electrospun polymer nanofibres
has focused extensively on biomedical products. Tissue
engineering has been recognized, for some time, as a
promising alternative to the use of autografts or
allografts for tissue reconstruction and regenera-
tion.44,45,77 This approach utilises cells, biomaterial
scaffolds and signalling molecules for the repair of
diseased or damaged tissues. However, other applica-
tions are also envisaged, such as wound dressings and
prostheses.
Wound dressing
An ideal dressing will cover and protect a wound,
providing an environment at the surface of the wound in
which healing can take place at the maximum rate, with
good dermosthetic appearance.200 Modern dressings are
6 A–C schematic illustration of collectors based in gold electrodes deposited over insulating substrates and D–F dark
field optical micrographs of PVP nanofibres collected between electrodes A–C respectively (adapted from Ref. 85:
!2004 Wiley-VCH Verlag)
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developed to serve the purpose of facilitating wound
healing apart from the basic function of covering
wounds and protecting them from infections. It has
been noted by several authors79,183,200 that an ideal
dressings is required to:
(i) be haemostatic
(ii) be efficient as a bacterial barrier
(iii) absorb excess exudates
(iv) provide and maintain a moist environment or
appropriate water vapour transmission rate,
and provide adequate gaseous exchange
(v) conform to the limits of the wound area
(vi) adhere to healthy tissue but not to wound
tissue, i.e. to show functional adhesion
(vii) be painless to the patient and easy to remove
(viii) provide these qualities at an affordable cost.
Current efforts using polymer nanofibrous membranes
as medical dressings are still at an early stage (Fig. 7).
Fibrinogen is a soluble protein that is present in the
blood plasma and has been shown to play a key role in
wound healing. Human and bovine fibrinogen nanofibre
mats have been electrospun and developed for their
potential use as a tissue engineered scaffold, wound
dressing or haemostatic bandage.69,79,183 Electrospun
poly(ethylene-co-vinyl alcohol) membranes also appear
to be favourable substrates for tissue engineering,
wound coverage and healing; one has been shown to
support the culturing of aortic smooth muscle cells and
dermal fibroblasts.67 Recently, cytocompatibility and
cell behaviour of primary normal human keratinocytes
(NHK) and fibroblasts cultured on silk fibroin (SF)
nanofibrous membranes were also reported.115,116 The
adhesion of cultured cell types was evaluated using type
I collagen, fibronectin or laminin as substrates, which
were adsorbed onto the SF nanofibres. The results
indicated that type I collagen, one of the integrin
ligands, is functionally active in terms of cell adhesion
onto the electrospun SF nanofibres for both keratino-
cytes and fibroblasts tested. In another study, the same
research group produced a nanofibrous matrix of type I
collagen from calfskin via electrospinning.135 In cell
activity assessment, electrospun collagen nanofibres
coated with type I collagen or laminin were found to
promote cell adhesion and spreading of NHK.
Additionally, the effect of collagen nanofibres on open
wound healing in rats and athymic mice133 was very
effective as wound healing accelerators in early stage
wound healing. In those studies, SF and type I collagen
nanofibre non-wovens produced by electrospinning were
introduced for wound dressing and scaffolds for tissue
engineering. The performance of electrospun nanofi-
brous polyurethane (PU) membranes as dressings was
examined in vivo using a pig model.69 To validate the
application in the medical field, morphological proper-
ties of the membranes were characterised and wound
healing was investigated. This wound dressing showed
controlled evaporative water loss, excellent oxygen
permeability and promoted fluid drainage owing to the
presence of porous nanofibres and the inherent proper-
ties of PU. Histological examination confirmed that
epithelialisation rate was increased and the exudate in
the dermis was well controlled by covering the wound
with the electrospun membrane.
Medical prostheses
Polymer nanofibres fabricated via electrospinning have
been proposed for a number of soft tissue prostheses
applications, such as arterial blood vessel50,159 and
breast.132 Electrospun biocompatible polymer nanofi-
bres can also be deposited as a thin porous film onto a
hard tissue prosthetic device designed to be implanted
into the human body.19
The search for vascular grafts substitutes has been a
half century endeavour. Although polytetrafluoroe-
thylene180 and polyethylene terephthalate (PET)
(Dacron)182 have been successful in treating the pathol-
ogy of large diameter arteries (.6 mm, inner diameter),
no materials have been successful in replacing small
diameter blood vessels (,6 mm). The first approach
using the electrospinning technique to obtain biomi-
metic vascular graft scaffolds was developed by Stitzel
and colleagues.162 The graft was fabricated with collagen
fibres wound on a stainless mandrel and covered with
electrospun PLA. The vascular construct was seeded
with human aortic smooth muscle cells (SMCs) and
general cellular orientation along the principal stress
lines was observed. In a recent article, Venugopal et al.177
reported the development of biocomposite nanofibre
scaffolds of PCL and collagen types I and III. In vitro
studies with coronary artery SMCs revealed that these
biocomposites constitute promising scaffolds for the
regeneration of smooth muscle tissue for blood vessel
engineering.
In recent years, creating a biodegradable polymer
scaffold with an endothelialised surface has become an
attractive concept for replacement of small diameter
blood vessels. Taking this into account, Xu et al.189
cultured human vascular endothelial cells (ECs) on
electrospun and solvent cast poly(L-lactic acid) (PLLA)
substrates with different surface roughness and showed
that EC function was enhanced on the smooth solvent
cast surface relative to the rough electrospun surface of
PLLA nanofibres. Interestingly, in previous work,118,188
the same research group demonstrated that a nanofibre
matrix of the block copolymer of poly(L-lactic acid)-co-
poly(e-caprolactone), P(LLA-CL), could support the
adhesion and proliferation of ECs and SMCs. This
synthetic nanofibre matrix combined the advantages of
synthetic biodegradable polymers with the biocompa-
tible mimicking architecture of extracellular matrix, to
have great potential for blood vessel engineering. To
facilitate viability, attachment and phenotypic main-
tenance of human coronary artery ECs, an electrospun
collagen coated P(LLA-CL) nanofibre mesh was
7 Mouse lung fibroblasts (L929 cell line) adhered on
plasma modified PCL nanofibre meshes
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fabricated through plasma treatment followed by
collagen coating.49 The collagen coated nanofibrous
structure also showed mechanical properties suitable for
tissue engineered vascular grafts (Fig. 8). A similar study
was recently presented by Jeong et al.,58 demonstrating
the effectiveness of a dynamic culture on the engineering
of vascular grafts. Additionally, for prosthetic vascular
grafts, directional bias of fibres with respect to the
tubular axis is required to mimetically obtain aniso-
tropic vascular grafts so as to improve burst strength.
Aligned P(LLA-CL) nanofibrous scaffold have been
successfully produced.187 Cell culture results of SMCs
on the nanofibrous scaffold indicated that cells adhered
and migrated along the direction of aligned nanofibres,
showing a significant improvement over polymer films.
Vascular graft scaffolds have also recently been
fabricated using electrospun polymer blends of type I
collagen from calf skin (45%), elastin from ligamentum
nuchae (15%) and PLGA (40%).161 The biocompatibility
of the scaffolds was tested with bovine ECs and SMCs
and assessed by MTT metabolic assay and neutral red
assays. The biocompatibility of the electrospun vascular
scaffolds was also tested in vivo. Favourable interactions
between SMCs and ECs on the scaffold were demon-
strated by cellular morphology, histology and immu-
nostaining. Ma et al.103 processed a conventional
polymer used in vascular grafts, PET, into non-woven
nanofibre mat via electrospinning. To overcome the
chemical and biological inertness of the PET surface,
gelatin was covalently grafted onto the PET nanofibrous
surface. Endothelial cells were cultured on the original
and gelatin modified PET nanofibre meshes and results
demonstrated an improvement of spreading and pro-
liferation of the ECs, maintaining their phenotype.
Altogether, these studies demonstrate the potential of
electrospinning as a method to fabricate functional
vascular grafts for clinical applications, using different
biomaterials.
Drug delivery systems
The ability to influence the fibre diameter, by changing
the polymer solution concentration and/or its surface
tension, and the ability to incorporate therapeutic
compounds into the mats during spinning afford the
prospect of preparing useful polymer systems for
controlled drug delivery. Moreover, two potential
advantages of the electrospinning approach are the
avoidance of melt processing, which is especially
important for heat sensitive drugs, and minimisation
of the initial burst. The nature of the polymer can direct
the use of the electrospun fibres with water soluble
polymers giving rise to immediate release dosage forms
and water insoluble (i.e. biodegradable or non-biode-
gradable) polymers, being useful for sustained release
systems. Thus, the fabrics generated with water soluble
carriers could be used in oral dosage formulations by
direct incorporation of the materials into a capsule or
by further processing (i.e. milling of the fabrics).178
Covalent conjugation of drugs to polymers represents an
alternative strategy for moderating the rates of drug
release. This strategy, however, requires the presence of
side chains/functional groups, which are generally only
abundant in some hydrophilic biodegradable polymers.
Unfortunately, the electrospun membranes prepared
from hydrophilic polymers generally have poor mechan-
ical strength, especially in their swollen state, and also
tend to disintegrate faster in vivo. Moreover, chemical
cross-linking is generally needed to solidify and stabilise
the electrospun membranes prepared from hydrophilic
polymers, and most of those chemical reactions have
potential toxicity. In addition, hydrophilic and water
soluble polymers tend to leach out rapidly from the
blends when incubated in an aqueous environment.
Thus, it is necessary to find hydrophilic polymers that
are soluble in organic solvents and insoluble in water
under physiological conditions, for preparing composite
electrospun membranes.60
Drug delivery devices including polymer nanofibres
are based on the principle that dissolution rate of a drug
may be mediated by the surface area of both the drug
and the corresponding carrier. Since drugs and carrier
materials can be mixed together to produce nanofibres
by electrospinning, various interaction modes in the
resulting nanostructured products can be envisaged:
(i) the drug as tiny particles attached to the surface
of the nanofibre carriers
(ii) both drugs and carriers are in nanofibre form,
resulting in an interlaced structure
(iii) a blend of drugs and carrier materials integrated
into a single type of composite nanofibre
(iv) the carrier material is electrospun into a
tubular form in which the drug particles are
encapsulated.
Modes (i) and (ii) tend to give rise to a problem of burst
release in the initial stages of incubation and therefore,
modes (iii) and (iv) may be preferred.54
Kenawy et al.66 were the first to describe the
incorporation of a drug into polymeric nanofibres.
They found that electrospun poly(ethylene-co-vinylace-
tate) (PEVA) released 65% of its drug (tetracycline
hydrochloride) content within 120 h, whereas the 50 : 50
A SEM image of tube; B magnified image of region 3 in micrograph (from Ref. 75: !2005 Elsevier
8 Fabricated bilayered tubular construct composed of polyurethane tube with interior surface coated with collagen
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material (PEVA/PLA) released y50% over the same
time period. Mats of PLA fibres exhibited some
instantaneous release, most probably caused by tetra-
cycline hydrochloride on the fibre surfaces. In addition,
the percentage of tetracycline released after 5 days from
electrospun PEVA was only about twice that released
from Actisite (tetracycline periodontal fibres). In gen-
eral, the total percentage release from the cast films was
lower than that from the electrospun mats, as would be
expected due to the much lower surface area of the
former. In other work, bioabsorbable nanofibre mem-
branes of PLA were used for loading an antibiotic drug,
Mefoxin (cefoxitin).205
For potential use in topical drug administration and
wound healing, poorly water soluble drugs loaded in
water soluble and water insoluble nanofibrous polymer
carriers were investigated.178,179 Verreck et al.179
reported that solvent casting and melt extrusion of
hydroxypropylmethylcellulose results in samples that
rapidly release itraconazole, with the solvent cast film
giving more complete release. Samples produced using
electrostatic spinning resulted in a complete in vitro
release over time, but the dissolution rate was slower
than for either the cast thin films or the melt extruded,
milled powder. Additionally, it was shown that drug
loaded polymer electrospun nanofibres were able to
disperse drugs in an amorphous state, which facilitates
drug dissolution.
Zeng and co-workers198 described a perfect inclusion
of Rifampin and Paclitaxel inside PLLA fibres, in that
no burst release of drug was observed. These drugs are
lipophilic and highly soluble in PLLA/chloroform/
acetone solution. When the solution jet was rapidly
elongated and the solvent evaporated quickly, the drug
remained compatible with PLLA. Doxorubicin hydro-
chloride (a hydrophilic drug) was also used in this study
and limited solubility in the electrospinning solution was
reported. During the rapid evaporation of the solvent,
phase separation took place quickly between the drug
and PLLA. Therefore, the solubility and compatibility
of the drug in the drug–polymer–solvent system was a
decisive factor.
Electrospun nanofibrous meshes can also be used as
carriers for hydrophilic drugs, where the drug release
profile can be finely controlled by the modulation of
scaffold morphology, porosity and composition. By
taking advantage of the unique solubility characteristics
of poly(ethylene glycol)-g-chitosan (PEG-g-CHN), Jiang
and colleagues60 prepared by electrospinning a highly
porous composite membrane composed of PLGA and
PEG-g-CHN, without the need for cross-linking. These
membranes are mechanically robust and flexible, and
have high porosity, hydrophilicity and capacity to
sustained release of ibuprofen, rendering them suitable
for direct application to atrial tissue. Kim and co-
workers71 successfully incorporated a hydrophilic anti-
biotic drug, Mefoxin (cefoxitin sodium), into electro-
spun PLGA and PLGA/PLA/PEG-b-PLA (80 : 5 : 15)
nanofibres, without the loss of structure and bioactivity.
It was demonstrated that the introduction of an
amphiphilic PEG-B-PLA block copolymer in the poly-
mer matrix reduced the cumulative amount of the
release at earlier time points and prolonged drug release
rate to 1 week. In addition, the released cefoxitin sodium
from electrospun scaffolds was found to be structurally
intact as well as effective in Staphylococcus aureus
growth inhibition, in both static and dynamic environ-
ments.
The use of electrospun fibres as drug carriers will be
also promising in future biomedical applications,
especially post-operative local chemotherapy. Along
those lines, Katti et al.65 reported the development of
a novel bioresorbable, polymeric nanofibre based anti-
biotic delivery system for the treatment of wounds;
Cefazolin was incorporated into PLGA nanofibres using
the free acid form of the antibiotic. Zong et al.204
examined the effect of using electrospun non-woven
bioabsorbable PLGA impregnated with antibiotics
(Mefoxin) as an anti-adhesion membrane based on an
in vivo rat model. These delivery systems would
potentially have two functions: as a topical/local
antibiotic delivery system and as a resorbable/biode-
gradable gauze whose degradation products are easily
metabolised by the body. A particular advantage of this
delivery system would be the possibility of delivering
uniform and highly controlled doses of bioactive agents
at the wound site via the high surface area to volume
ratio of the nanofibre system. Another advance in post-
operative localised drug administration focused on
vascular grafts. Sustained delivery of heparin to the
localised adventitial surface of the grafted blood vessels
has been shown to prevent vascular smooth muscle cell
(VSMC) proliferation leading to graft occlusion and
failure. Luong-Van et al.98 successfully incorporated
heparin into electrospun PCL fibre mats. The effect of
heparin incorporation on the fibre morphology was
studied, as well as heparin dispersion and release rates.
A homogeneous distribution of heparin was found
throughout the fibre mats and continuous diffusional
release over 14 days. In addition, the fibres did not elicit
a proinflammatory response, as assessed through in vitro
macrophage assay, and the released heparin was
effective in preventing the proliferation of VSMCs in
culture.
A number of authors59,65,66,71,98,179,198,204,205 have
successfully encapsulated drugs into electrospun fibres
by mixing the drugs in the polymer solution to be
electrospun. Fewer, however, have encapsulated pro-
teins in electrospun polymer fibres.20,143,196 Proteins
such as growth factors are often the most important
biochemical signalling agents for tissue engineering
applications. A recent study developed by Chew et al.20
demonstrated the feasibility of encapsulating human
nerve growth factor (NGF) by electrospinning it into
a biodegradable fibre composed of the copolymers
poly(e-caprolactone) and ethyl ethylene phosphate
(PCLEEP). Partially aligned protein encapsulated fibres
were obtained and the protein was found to be randomly
dispersed throughout the electrospun fibrous mesh in
aggregate form. A sustained release of NGF from
electrospun fibrous mesh for up to 3 months was
observed. Additionally, it was confirmed that the NGF
released at the end of this time period was, at least
partially, bioactive in stimulating PC12 cells differentia-
tion into neurons. In another study, Zeng et al.196
reported the release of comparable large proteins from
electrospun poly(vinyl alcohol) (PVA) nanofibres
obtained by electrospinning. The release of fluorescin
isothiocyanate labelled bovine serum albumin or lucifer-
ase from electrospun PVA nanofibres was demonstrated;
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the burst release was retarded significantly by a post-
electrospinning coating of highly hydrophilic poly(p-
xylylene). The preservation of enzyme activity and the
continuous release of the intact enzyme from the
immersed fibres meet a fundamental prerequisite for
the application of enzymes or other sensitive agents
released from electrospun nanofibres under physiologi-
cal conditions.
DNA release
Fibres produced by electrospinning form a large,
interconnected porous network that is ideal for drug,
gene, as well as cell delivery. Fang and Reneker34 have
previously reported on electrospinning of DNA fibres,
utilising purified genomic DNA (calf thymus Na-DNA)
as the polymer. Luu et al.100 utilised the unique
capabilities of electrospinning to develop a biologically
active scaffold for gene delivery. This study appears to
be the first report describing the successful dispersion of
plasmid DNA into polymeric solutions of PLA-PEG
and PLGA, generating biologically active composite
scaffold via electrospinning. Preliminary data indicate
that, by manipulating the scaffold’s properties (fibre
diameter, porosity or pore size), it should be possible to
accurately control the release of DNA from the scaffold,
and thus decrease the rate of release at earlier times and
sustain a more linear release for longer time periods.
Additionally, these results indicated that the DNA
released from the scaffold was not only intact, but also
capable of cellular transfection. In a subsequent study,
the same group95 developed a novel core–sheath DNA
nanoparticle composed of condensed plasmid DNA in a
triblock copolymer of poly(lactide)-b-poly(ethylene gly-
col)-b-poly(lactide). The mixture of encapsulated DNA
and PLGA was then electrospun to form a non-woven
nanofibrous and nanocomposite scaffold. This structure
was capable of controlled release bioactive plasmid
DNA in an intact form and transfect preosteoblastic
MC3T3 cells in culture. Together, these results demon-
strated that by understanding and using the molecular
interactions of block copolymers and plasmid DNA in
solution, novel structures and additional functionality
can emerge. A deep understanding on the molecular self-
assemblies and the electrospinning process has enabled
the development of an effective gene delivery vehicle.
Tissue templates/scaffolds
A biodegradable scaffold is commonly recognised as an
indispensable element in engineering living tissues.
Scaffolds are used as temporary templates for cell
seeding, proliferation and differentiation, to lead to the
regeneration of the tissue.1,44,45,77 The design of bioma-
terial scaffolds for tissue engineering is an attempt to
obtain functional replacement of the ECM, to support
the desired cellular differentiation and maintain pheno-
type specific activities. Nanofibrous materials, by virtue
of their morphological similarities to natural ECM, have
been considered as promising scaffolds for tissue
engineering applications. The difficulties with these
structures include poor control of porosity and limited
mechanical properties.
Diverse tissues that undergo injury could benefit from
the potentialities of the nanofibrous structures produced
by electrospinning. For instance, in cartilage regenera-
tion, induction and maintenance of chondrocyte differ-
entiation are obtained by embedding cells in agarose, or
alginate, or in the form of a high density pellet.
However, such cultures lack the mechanical stability
provided by PCL nanofibrous scaffold, as described by
Li et al.89 In subsequent work,94 it was demonstrated
that electrospun nanofibres of PCL effectively support
transforming growth factor b1 induced chondrogenesis
of adult human mesenchymal stem cells (hMSCs). The
level of differentiation appeared to be equivalent to that
observed in high density pellet cultures of hMSCs. In
addition, nanofibrous scaffolds allowed cells to be
grown on the same surface throughout their entire
course of differentiation and maturation. The same
group, in another study,93 showed that PCL nanofibrous
scaffolds not only support the maintenance of a
chondrogenic phenotype, but also provide a suitable
scaffold for the osteogenic, chondrogenic and adipo-
genic differentiation of hMSCs. In a recent study,
Subramanian et al.164 have evaluated a novel electro-
spun chitosan/polyethylene oxide (PEO) mat composed
of oriented submicron fibres for its tensile properties and
biocompatibility with canine chondrocytes (cell attach-
ment, viability and proliferation). The results demon-
strated that the electrospun aligned fibres had a higher
modulus than anisotropic cast films, and provided
good chondrocyte biocompatibility. A similar biological
study,11 with chitosan/PEO nanofibres deposited as a
non-woven membrane or as a highly aligned bundle, was
developed with human chondrocytes (HTB-94 cell line)
and osteoblasts (MG-63 cell line). Experimental results
showed that the nanofibrous structure promoted adhe-
sion and maintained characteristic cell morphology and
viability throughout the period of study, properties of
particular interest in tissue engineering for controlled
drug release and tissue remodelling. In other recent
work,3 starch based nanofibre meshes were presented as
support structures for bovine articular chondrocytes
proliferation and maturation, as demonstrated by the
formation of extracellular matrix (glycosaminoglycans
quantification) and immunoexpression of collagen types
I and II.
Interesting work by Yoshimoto et al.193 demonstrated
that electrospun PCL nanofibres are capable of support-
ing attachment and proliferation of rat bone marrow
derived MSCs, which maintain their phenotypic shape
and differentiation into osteoblastic cells under dynamic
culture conditions. Shin et al.152 implanted MSC–PCL
constructs subcutaneously in rats and showed new bone
formation at the implantation site. These results were
later confirmed by Boudriot and colleagues,17 who
demonstrated osteogenic differentiation of hMSCs on
a three-dimensional matrix of electrospun PLLA nano-
fibres. Therefore, nanofibrous structures processed by
electrospinning could also be promising scaffolds for
bone tissue engineering. Recently, Zhang et al.201
coelectrospun gelatin with PCL to produce composite
fibrous scaffolds, which exhibited improved mechanical
properties (namely, elongation and deformation), as well
as more favorable wettability, than nanofibres obtained
from either gelatin or PCL alone. Additionally, cell
culture experiments with bone marrow stromal cells
(BMSCs) showed favourable interactions (i.e. attach-
ment and spreading) and cellular migration into the
fibrous structure of this artificial polymeric material. In
a recent study, guided bone regeneration (GBR)
composite nanofibre membranes were successfully
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fabricated by electrospinning of PCL/calcium carbonate
(CaCO3).
39 Human osteoblasts (hFOB1?19 cell line)
were cultured on composite nanofibrous GBR mem-
branes, and MTS assay and SEM observation revealed
good cell attachment and proliferation. Another
study185 had also evaluated the osteoblast attachment
and proliferation on composites of PCL nanofibres
containing nanoparticles hydroxyapatite (HA). Results
demonstrated that cells seeded on PCL/HA fibrous
scaffolds presented higher viability than the cells seeded
on scaffolds containing PCL/CaCO3 or PCL alone. That
behavior was attributed to the ability of HA to promote
bone cell activities. Recently, the formation of an apatite
layer has been induced over electrospun PCL nanofibre
meshes, without the occurrence of pore occlusion.4 The
biological influence of this biomimetic coating on
osteoblatic like cells was assessed. It was shown that
PCL nanofibre meshes coated with an apatite layer
support and enhance the proliferation of osteoblasts for
long culture periods (Fig. 9).
Nair and colleagues122 recently produced non-woven
nanofibre meshes from poly[bis(p-methylphenoxy)pho-
sphazene] (PNmPh) by electrospinning. This biodegrad-
able polymer is a polyphosphazene, a class of inorganic–
organic polymers known for their high biocompatibility,
high temperature stability and low temperature flex-
ibility. Furthermore, the electrospun nanofibre mats
were studied to evaluate the biological performance. It
was found that these mats supported the adhesion of
bovine coronary artery endothelial cells, as well as
promoting adhesion and proliferation of osteoblastic
like MC3T3-E1 cells (mouse immortalised calvarial
cells). This study indicated that the PNmPh nanofibre
matrices could promote cell matrix and cell–cell inter-
actions, making them potential candidates for various
biomedical applications.
Many researchers62,82,112,115,116 have investigated silk
proteins, mainly SF, as candidate materials for biome-
dical applications, because it has several distinctive
properties including good biocompatibility, good oxy-
gen and water vapour permeability, biodegradability
and minimal inflammatory reaction. Jin et al.62 reported
the ability of electrospun silk matrices to support human
BMSCs attachment, spreading and growth in vitro,
suggesting the potential use of these biomaterial
matrices as scaffolds for tissue engineering.
Electrospun silk fibroin mats were comparable with
other biodegradable electrospun mats using PGA,15,116
PLGA,90,100,139,186 collagen,109,110,202 collagen/PEO
blends52 that were tested for use as scaffolds for tissue
regeneration. In fact, smooth muscle cells were observed
to infiltrate an electrospun collagen (calfskin) nanofibre
matrix and were well integrated into the network within
7 days of culture.110 Matthews109 also performed an in
vitro study with chondrocytes, where it was also
demonstrated that electrospun collagen type II scaffolds
support cell proliferation and are readily infiltrated.
More recently, a comparative study of collagen, gelatin
(denaturated collagen), solubilised alpha-elastin and
recombinant human tropoeslatin as biopolymeric mate-
rials for fabricating tissue engineering scaffolds by
electrospinning was developed by Li and colleagues.88
In contrast to collagen and gelatin, which could be spun
into fibres in the nanometre scale, the diameter of alpha-
elastin and tropoelastin fibres was always in the range of
microns. The characterisation of the mechanical tensile
moduli of electrospun fibres was also reported. Cell
culture studies confirmed that these electrospun engi-
neered protein scaffolds support attachment and growth
of human embryonic palatal mesenchymal cells.
Numerous topographical and chemical strategies have
been undertaken to create micro- and nanoscale
enhanced features to regulate cell morphology and
function.35,160,181 In fact, very little was previously
known about the textural effects of the fibrous matrix
on tissue engineering. Park et al.115 studied the
cytocompatibility and human oral keratinocytes beha-
viour on the different textures of SF (woven matrix of
microfibres, films and non-woven matrix of nanofibres).
Their results indicated that the SF nanofibre matrix
promotes cell adhesion and spreading, using type I
collagen as substrate, better than SF film and SF
microfibre matrices. In subsequent work,117 they demon-
strated that a PLGA/chitin composite non-woven
matrix can be a better candidate than the PLGA non-
woven matrix in terms of cell adhesion and spreading for
normal human keratinocytes, and that the PLGA and
PLGA/chitin matrices are good matrices for normal
human fibroblasts. These nanofibrous matrices showed
promise for biomedical applications, such as wound
dressing and scaffolds for tissue engineering. In a
different topographical approach, nano- to microstruc-
ture biodegradable poly(L-lactide-co-e-caprolactone)
fabrics were prepared by electrospinning.74 Physical
characterisation revealed that a decrease in the fibre
diameter of the fabric resulted in a decrease in the
porosity and on the pore size. This was followed by an
increase in fibre density and mechanical strength.
Biological assays demonstrated that human umbilical
vein endothelial cells (HUVECs) were well adhered and
9 SEM images of A micrografts of electrospun poly(e-caprolactone) nanofibre meshes after biomimetic calcium phos-
phate coating, keeping porous morphology (from Ref. 108) and B morphology of Saos-2 cells cultured for 14 days on
PCL nanofibre meshes coated with biomimetic coating (from Ref. 4)
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proliferated on the small diameter fibre fabrics (0?3–
1?2 mm in diameter), whereas markedly reduced cell
adhesion, restricted cell spreading and no signs of
proliferation were observed on the large diameter fibre
fabric (y7?0 mm in diameter). The discussion suggests
that electrospun elastomeric nanofibre fabric may be
useful as temporary functional scaffolds in cardiovas-
cular and muscular tissue engineering.
Nanofibrous structures were recently proposed as a
potential cell carrier for neural tissue engineering by
Yang et al.191 Production of PLLA nanofibrous scaf-
folds and the biological performance of neural stem cells
(NSC) when seeded into those scaffolds was described.
It was concluded that this nanostructure supports neural
stem cell adhesion and enable NSCs differentiation and
outgrowth of neurites. Later, the production of perfectly
aligned PLLA fibrous scaffolds was achieved and in vitro
studies demonstrated the elongation and neuritis out-
growth of NCS parallel to the direction of fibre
alignment.190 Moreover, a comparative study with
electrospun microfibres revealed a significant effect on
the cell orientation. However, the NSC differentiation
rate was higher for nanofibres than for microfibres.
Several studies on creating cardiac muscle cell
constructs have also been reported.151,203 Studies that
used a synthetic polymer scaffold typically concluded
that the stiffness of the scaffold hindered tissue
contractions.1,74 A study developed by Shin et al.151
introduced an in vitro system for engineered myocar-
dium using a degradable, nanofibrous scaffold made of
PCL by electrostatic fibre spinning. The cardiomyocytes
penetrated the entire scaffold and stained positively for
cardiotypical proteins, i.e. actin, tropomyosin and
cardiac troponin-I. The work presented provides an
alternative approach to engineered myocardium by
relying on a synthetic polymer that provides sufficient
stability and low opposition to contractions. In a similar
approach,203 biodegradable polymer nanofibres of
PLLA and PLGA (PLA10-GA90zPLLA and
PLGAzPEG-PLA) were assessed for use in heart and
cardiac tissue constructs. Primary rat cardiomyocytes
(CMs) were cultured onto nanofibrous scaffolds and a
dense multilayer of cells was obtained. It was also
observed that CMs over electrospun PLLA scaffolds
developed mature contractile structures (sarcomeres).
Skeletal muscle tissue engineering represents an
attractive approach to overcome problems associated
with autologous transfer of muscle tissue and provide a
valid alternative for tissue replacement in the enhance-
ment of muscle regeneration. In this context, Riboldi
et al.136,137 investigated the potential use of electrospun
DegraPol (degradable polyesterurethane) membranes as
fibrous scaffolds for skeletal muscle tissue engineering. To
evaluate their suitability for this specific application,
scaffolds were characterised with reference to their
morphological, degradative and mechanical properties.
Subsequently, cell viability, adhesion and differentiation
on coated (with collagen, fibronectin and Matrigel, a
gelatinous protein mixture) and uncoated DegraPol
electrospun membranes were investigated using murine
and rat myoblast cell lines (C2C12 and L6 respectively)
and primary human satellite cells. The electrospun
DegraPol membranes showed satisfactory mechanical
properties (linear elastic behaviour up to 10% deforma-
tion, E modulus of the order of megapascals) and good
cellular response in preliminary adhesion and differentia-
tion experiments (cellular adherence and proliferation on
differently coated electrospun membranes, accompanied
with positive staining for myosin heavy chain).
Originally, in the field of liver tissue engineering,
galactosylated nanofibre meshes were suggested as
potential scaffolds by Chua et al.21 In this study, highly
porous nanofibre scaffolds of PCLEEP were grafted
with poly(acrylic acid) and subsequently, covalently
conjugated with galactose ligands. Hepatocytes, isolated
from male Wister rats, cultured on galactosylated
scaffolds, exhibited similar functional profile in terms
of cell attachment, ammonia metabolism, albumin
secretion and cytochrome P450 enzymatic activity as
those on the functional two-dimensional substrate.
Galactosylated PCLEEP nanofibre mesh demonstrated
the unique properties of promoting hepatocyte aggre-
gates within the mesh and around the fibres, forming an
integrated spheroid nanofibre construct. Indeed, this
construct would be advantageous in the design of
bioartificial liver assisted devices.
Mechanical forces play a central role in the physiol-
ogy of a wide variety of tissues. Several researchers10,142
have reported that cyclic mechanical stretch increases
ECM production in cultured fibroblasts on flexible
membranes. Additionally, when connective tissue cells
are grown on deformable substrates and subject to an
applied cyclic strain field, the cells align perpendicular to
the greatest strain direction. Lee et al.80 studied the
effect of fibre alignment in polyurethane nanofibres and
direction of mechanical stimuli on the ECM generation
of human ligament fibroblast (HLF). The results
indicated that HLF cultured in aligned nanofibres had
a similar morphology to ligament fibroblasts in vivo. The
aligned structure led to increased ECM production, and
the aligned HLFs were more sensitive to strain in the
longitudinal direction. Consequently, aligned nanofibres
can constitute a promising base material for tissue
engineered ligament in that they are a biomimetic
structure and provide the mechanical environment
ligament fibroblasts encounter in vivo.
Desired properties of electrospun
nanofibres as scaffolds
Tissue engineering is emerging as an alternative
approach for the (re)generation of functional tissues
damaged by disease or trauma, and in replacing failing
or malfunctioning organs. Biomaterials play a signifi-
cant role in these modern strategies of regenerative
medicine and tissue engineering. They can be used to
tailor the biophysical and biochemical milieus that direct
cellular behaviour and function into the desired regen-
eration of tissues. Moreover, the scaffold should act as a
template for the neovascularisation of the regenerated
tissue and could actively participate in the regeneration
process through the release of growth/differentiation
factors. Various degradable biomaterials, either natural
or synthetic, have been processed into scaffolds for
tissue engineering.1,6,44,45,99,106,107 Essentially, the suc-
cess of tissue engineering methods is highly dependent
on the properties of the scaffold. Basic scaffold design
requirements include biodegradability, biocompatibility,
high surface area/volume ratio (porosity and intercon-
nectivity) and mechanical integrity.1,55,63,119,141
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It is agreed99,119 that a candidate scaffold should
closely mimic the structural and functional properties of
the materials found in the native ECM of the host tissue.
Therefore, the ultimate goal of the scaffold is the
production of an ideal structure that can replace the
natural ECM until host cells can repopulate and
resynthesize a new natural matrix. It is well known that
most natural ECMs are composed of randomly oriented
fibrils of nanometre scale diameters. The morphology
and architecture of the electrospun structure aims at
being similar to those of some natural ECMs.155,200
Biological performance is regulated by the biological
signals from growth factors, extracellular matrix, and
also by the surrounding cells. More sophisticated efforts
to mimic this natural scaffold are being pursued by
many groups that are exploring the development of
biomaterial/biochemical composites incorporating bio-
logical agents such as growth factors and other key cell
regulatory molecules.40,131 This objective has also been
pursued using electrospun nanofibre meshes, although
little attention has to date been given to the loading
growth factors.20,143
The pores of a tissue engineering scaffold constitute
the space in which the cells reside. It is generally agreed
that a highly porous microstructure with interconnected
pores and a large surface area is desirable to allow cell
seeding and migration throughout the material.
Furthermore, the scaffolds should exhibit adequate
microporosity, to encourage capillary ingrowth. High
porosity provides more opportunities for cell colonisa-
tion and makes the diffusion of gases, nutrients and
metabolic waste between scaffold and environment more
efficient. Given the importance of the pore structure of
tissue engineering scaffolds, a variety of techniques have
been proposed to obtain an appropriate substrate for cell
culture.8,22,23,30,44,46,47,56,63,76,105,114,120,127,128,153,154,156,168,176,184
Many of these techniques employ organic solvents or high
temperature, and the preservation of biocompatibility and
the crystalline structure of the polymer are problematic.
To overcome the above limitations, electrospun fibrous
matrices can be used as alternative scaffolds in tissue
engineering applications. When nanofibres are created in
the electrostatic field, they are deposited randomly on the
collector, layer by layer, and a wide variety of pore
diameters (distances between fibres) are
formed.60,68,74,100,193 However, the strongest limitations
of nanofibrous structures are their inherent two-dimen-
sional character and the difficulty in controlling pore size.
In most tissue engineering applications, it is desirable to
have scaffolds with a pore size that enables migration of
the cells into the inner regions of the structure. The cells
must remain viable, thus requiring an efficient exchange of
nutrients and metabolites with the culture medium. The
porosity of the electrospun meshes hinders the migration
of cells, but is suitable for diffusion of nutrients and
metabolites. Thus, new developments of the technology
are needed to overcome the difficulty of cell migration
when seeded at the mesh surface. Furthermore, the degree
of porosity always influences other properties of the
scaffolds such as mechanical stability, and its value should
always be balanced with the mechanical needs of the
particular tissue that is targeted.
The purpose of a scaffold is not only to provide a
surface for cell residence but also to maintain
mechanical stability at the host defect site. Mechanical
stability is dependent primarily on the selection of the
biomaterial, the architectural design of the scaffold and
the cell–material interactions.1,63 A well designed tissue
engineered scaffold has to meet, at least, two mechanical
requirements to be effective. The scaffold must retain
structural integrity and stability when a physician
handles and implants it into the defect site of the host.
After surgery, the structure at the implant site must
provide sufficient biomechanical support during the
process of tissue regeneration and structure degrada-
tion. Electrospun fibres have nanostructured surface
morphologies with small pores that influence mechanical
properties like tensile strength and modulus.49,74,137,201
Also, aligned nanofibre composites provide better
mechanical properties than a randomly aligned nano-
fibre composite structure.70,147
It is also highly desirable to use processing methods
that are efficient and that can be used to regulate the
chemical, biological and material properties of the
fabricated matrix.1,63 Methods such as solvent cast-
ing,120,153,154 fibre bonding,43,47,114,174 injection mould-
ing,22,23,46,156,168,176 and rapid prototyping,30,56,76,128,184
among others, have been used for the fabrication of
porous scaffolds. These scaffolds were proposed for
tissue engineering of various tissues including bone,
cartilage, tendon, blood vessel and heart
valve.44,45,55,78,148 However, most of the scaffolds could
only replace the lost tissue physically but not function-
ally.150 In electroprocessing, the shape of the scaffolding
and orientation of fibres within an engineered matrix
can be regulated by controlling the motion of target
mandrel and source polymeric solution. Presumably, the
incorporation of various degrees of cross-linking into
this type of nonwoven matrix can be used to further
tailor the material properties of the matrix to specific
applications. As a processing strategy, electrospinning is
rapid, efficient and inexpensive, and can be used to
fabricate complex, reliable scaffolds. For example,
blends201 or laminates199 of different materials can be
produced with this technique. Electrospinning can even
be used to incorporate slight structural adjustments into
an engineered material by regulating the orientation of
nanofibres within the fabricated network.79,110,169,187,190
A significant advantage of the electrospinning process
is the ability to fabricate non-woven, nanometre scale
fibrous structures.134 The architecture of the scaffold is
dynamically changed as the polymer fibres are hydro-
lyzed and degraded over time, which allows the
colonising cells to build up their own ECM.90 Indeed,
the main goal of tissue engineering is to develop a
biocompatible scaffold material which is degradable
over a controllable time scale into non-toxic products
that may disappear together with new tissue formation,
leaving natural tissue replacement.119 Thus, an electro-
spun structure composed of ultrafine nanofibres would
be more susceptible to hydrolysis than thicker fibres
when used to culture cells for tissue engineering
applications, because of enhanced water contact due to
the large surface area.89 However, the molecular weight
decrease during in vitro degradation of electrospun PCL
materials was much lower than those for solvent cast
PCL films, which may be due to enhanced diffusion of
oligomers out of the fibres (as a result of high surface/
volume ratio), which would reduce the effects of
autocatalytic degradation.12 Bo¨lgen and colleagues12
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demonstrated a faster degradation rate in vivo than in
vitro, attributed to the enzymatic degradation of PCL
in addition to the hydrolytic degradation. Recently,
Liang and collaborators95 established that the biode-
gradation rate, as well as the hydrophilicity of the electr-
ospun scaffolds, could be finely turned with different
material compositions (PLGA or PLA-b-PEG-b-PLA
triblock copolymer and DNA). It was demonstrated
that the electrospun scaffold containing those four com-
positions, which exhibited an ideal biodegradation
profile, good hydrophilicity and stable mechanical
properties in aqueous conditions, was suitable for
biomedical applications including biodegradable scaf-
folds for tissue engineering and prevention of post-
operative adhesions.72
Future directions
Electrospinning is a relatively old technology,37 which
has appeared in the literature for more than 70 years.
Despite the progress made in process modification and
control, considerable challenges remain.
Improved process models are needed to achieve better
understanding of the mechanisms and to explain
observed phenomena such as pore formation in nano-
fibres during electrospinning13 and formation of hollow
fibres.53,61,83,86,97 Another need is to model nanofibre
deposition on substrates, both stationary and moving, to
improve the nanofibre alignment when using newly deve-
loped processes,25,27,28,36,64,70,80,84,85,124,146,165,169–171,187,190
which may in itself lead to the development of novel
techniques. Models for multiple jet electrospinning should
also be improved, as well as the modelling of jet
interactions.172 In summary, a fundamental experimental
and theoretical analysis of the process is needed to develop
flexible and reliable methods to fabricate nanofibres and
their assemblies and composites.32
To date, most of the electrospun fibres obtained have
been synthetic. More attention should be given to
natural biopolymers, with the aim of achieving fibres
with better biocompatibility and performance. The
present authors believe that the successful conversion
of natural biopolymers into ultrafine and nanofibrous
structures will provide new opportunities and enhance
the possibilities of their use in bioengineering and other
demanding applications.
Core/sheath or hollow nanofibres are a more recent
revolutionary product of electrospinning. Application of
those structures in tissue engineering and regenerative
medicine will, it is hoped, allow drugs, growth factors,
enzymes, peptides or even DNA to be embedded into the
core of biodegradable polymer nanofibres, and released
as requried.102 In addition, using a synthetic polymer as
the core material and natural polymer as the shell
material, nanofibres with strong mechanical strength
and good biocompatibility should be obtained.199
Recently,57,173 the possibility of producing encapsu-
lated cells in microfibres (termed microthreads by the
authors) and meshes by electrospinning technology has
been explored (Fig. 10). In this approach, immortalised
(human brain astrocytoma cell line) and primary cells
(porcine vascular and rabbit aorta smooth muscle cells)
were loaded into poly(dimethylsiloxane) nanofibres,
using a coaxial needle configuration. It was demon-
strated that electrospun cells remain viable over long
culture periods, showing no evidence of cellular damage.
Work pioneering the incorporation of living cells into
electrospun nanofibres was carried out by Lee et al.81
and Salalha et al.,140 demonstrating efficient encapsula-
tion of viruses (M13) and bacteria (Escherichia coli and
10 Illustration of electrospinning process to embed living cells in fibre structure (from Ref. 173: !2006 ACS)
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Staphylococcus albus). Another approach157,158 used rat
aorta vascular SMCs electrosprayed simultaneously
with elecrospun poly(ester urethane) urea to produce a
hybrid tissue engineered construct. This approach,
denominated by ‘cellular microintegration’, was pro-
posed in the context of blood vessel replacement, aiming
to seed the cells during fabrication of nanofibrous
tubular scaffolds. Indeed, these biomicrofabrication
methods allow the production of biohybrid scaffolds
with promising applications in regenerative medicine, an
approach that will surely be further explored in future.
Biomaterial scaffolds are designed to support cell and
tissue growth, aiming on a macroscopic level to match
the properties of the organs to be replaced, without
being able to recreate the complexity and nanoscale
detail observed in real organs at the level of the matrix
interaction.160 The ability to engineer materials to a
similar level of complexity may become a reality,
through the fabrication of novel biodegradable poly-
meric matrices by combining electrospinning methodol-
ogies with well established techniques for materials
processing (e.g. injection moulding, solvent casting,
three-dimensional plotting). For example, a three-
dimensional micro-/nanostructure comprising electro-
spun nanofibres deposited on a wet spun microfibre
scaffold has recently been developed174 (Fig. 11). Its
biological functionality was demonstrated by the cultur-
ing of human osteoblast like cells, bone marrow stromal
cells and endothelial cells (HUVECs and microvascular
endothelial cells).144,145,174 This hierarchical structure
was developed to mimic the highly organised fibrous
structures of bone tissue, not forgetting the vascular
system. Combining nanostructured scaffold structures
with the incorporation of biological signals into the
scaffold fabric is also likely to prove a most rewarding
approach.99
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